Evans Jason Eric 4

What Happened

• Jason Evans, CEO of Surgery Partners, sold 20,400 shares on March 16, 2026 in an open-market/private sale (Transaction code S). The reported weighted-average price was $12.47 per share for a total value of $254,388. The filing indicates the sale was to satisfy tax withholding obligations tied to restricted stock that vested on March 4, 2026 (footnote F1).

Key Details

• Transaction date: 2026-03-16
• Transaction type: Sale (S) — open market or private sale
• Shares sold: 20,400 at a weighted-average price of $12.47; total reported value $254,388
• Reason given: Sold to satisfy tax withholding on vested restricted stock (F1)
• Price detail: $12.47 is a weighted average; reporting person can provide per-price share breakdown on request (F2)
• Shares owned after transaction: Not specified in this filing excerpt
• Filing timeliness: Reported on the same date as the transaction (filed 2026-03-16), so appears timely

Context

• This sale was a withholding-related disposition tied to a vesting event, which is a routine administrative transaction rather than an open-market sale intended to express a view on the company. Such tax-withholding sales are common when restricted stock vests and do not, by themselves, indicate management sentiment.